Sort by
Keyphrases
Patient Outcomes
100%
Immunophenotyping
100%
Adenocarcinoma
100%
KRAS mutation
100%
Diagnostic Biomarker
100%
Lung Adenocarcinoma
100%
Epidermal Growth Factor Receptor Gene
100%
Gene Alteration
100%
BRAF Gene
100%
ALK Gene
100%
Hazard Ratio
66%
Predictive Biomarker
66%
BRAF mutation
66%
Thyroid Transcription factor-1 (TTF-1)
66%
Clinically Significant
33%
Clinical Parameters
33%
Survival Prediction
33%
Diagnostic Algorithm
33%
Rodents
33%
Epidermal Growth Factor Receptor
33%
Multivariate Analysis
33%
Female Sex
33%
Overall Survival
33%
Growth Pattern
33%
Disease-free Survival
33%
Prognostic Effect
33%
Distinct Patterns
33%
Non-smoking
33%
Treatment Algorithm
33%
Pulmonary Adenocarcinoma
33%
Smoking History
33%
Complementation Group
33%
Thymidylate Synthase
33%
EGFR mutation
33%
ERCC1
33%
Adenocarcinoma Subtype
33%
Anaplastic Lymphoma Kinase Rearrangement
33%
Morphological Diagnostics
33%
Male Smokers
33%
Morphological Biomarkers
33%
Cytokeratin 7
33%
Failed Repair
33%
Napsin A
33%
Micropapillary Growth
33%
Lepidic Growth
33%
V-raf murine Sarcoma Viral Oncogene Homolog B1
33%
V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog
33%
Survival Parameters
33%
Adjuvant Radiochemotherapy
33%
Medicine and Dentistry
Adenocarcinoma
100%
Epidermal Growth Factor Receptor
100%
Gene Mutation
100%
Lung Adenocarcinoma
100%
Immunophenotyping
100%
Biological Marker
75%
Morphology
50%
Hazard Ratio
50%
Virus Oncogene
50%
Connective Tissue Cancer
50%
Health Care Cost
25%
Prevalence
25%
Overall Survival
25%
Chemoradiotherapy
25%
Disease Free Survival
25%
Micropapillary
25%
Anaplastic Lymphoma Kinase
25%
Homeobox Protein Nkx 2.1
25%
Thymidylate Synthase
25%
Keratin 7
25%
Excision Repair Cross-Complementing
25%
Multivariate Analysis
25%
Biochemistry, Genetics and Molecular Biology
KRAS
100%
Gene Mutation
100%
Epidermal Growth Factor Receptor
100%
Immunophenotyping
100%
Morphology
66%
Virus Oncogene
66%
Multivariate Analysis
33%
Ras2
33%
Prevalence
33%
Overall Survival
33%
Disease Free Survival
33%
Anaplastic Lymphoma Kinase
33%
Excision Repair Cross-Complementing
33%
Homeobox Protein Nkx 2.1
33%
Thymidylate Synthase
33%
Keratin 7
33%
Diagnostic Biomarker
33%
Deficiency
33%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Adenocarcinoma
100%
Adenocarcinoma
100%
Epidermal Growth Factor Receptor
100%
Biological Marker
75%
Connective Tissue Cancer
50%
Chemotherapy
25%
Overall Survival
25%
Prevalence
25%
Disease Free Survival
25%
Thymidylate Synthase
25%
Anaplastic Lymphoma Kinase
25%
Homeobox Protein Nkx 2.1
25%
Cytokeratin 7
25%